Sustained Liver Targeting and Improved Antiproliferative Effect of Doxorubicin Liposomes Modified with Galactosylated Lipid and PEG-Lipid

Verfasser / Beitragende:
[Shaoning Wang, Hui Xu, Jinghua Xu, Ying Zhang, Yingchun Liu, Yi-hui Deng, Dawei Chen]
Ort, Verlag, Jahr:
2010
Enthalten in:
AAPS PharmSciTech, 11/2(2010-06-01), 870-877
Format:
Artikel (online)
ID: 445107979